Advisortrust Partners’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$422K Sell
2,829
-16
-0.6% -$2.24K 0.13% 126
2026
Q2
$359K Buy
2,845
+137
+5% +$18.1K 0.12% 137
2026
Q1
$377K Buy
2,708
+153
+6% +$21.4K 0.16% 110
2025
Q4
$314K Buy
+2,555
New +$311K 0.14% 112

Other funds holding GILD

Advisortrust Partners's GILD Position: Q3 2026 in Review

Advisortrust Partners reduced its Gilead Sciences (GILD) stake by 0.56% in Q3 2026, selling an estimated $2.24K and leaving 2,829 shares worth $422K. The position accounts for 0.13% of the portfolio, ranked #126.

Advisortrust Partners first reported a position in GILD in Q4 2025 and has held it in 4 quarters since. 2,357 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Advisortrust Partners held 2,829 shares of Gilead Sciences worth $422K as of Q3 2026.
  • Advisortrust Partners sold 16 Gilead Sciences shares in Q3 2026, an estimated $2.24K.
  • Gilead Sciences made up 0.13% of Advisortrust Partners's portfolio in Q3 2026, its #126 holding.
  • Advisortrust Partners first reported a position in Gilead Sciences in Q4 2025 and has held it in 4 quarters since.
  • 2,357 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Advisortrust Partners's 13F filing for Q3 2026, filed 2 Nov 2026.